Select Medical Holdings Corp has a consensus price target of $36, established from looking at the 18 latest analyst ratings. The last 3 analyst ratings were released from Benchmark, UBS, and Benchmark on April 12, 2024, November 30, 2023, and November 8, 2023. With an average price target of $34.67 between Benchmark, UBS, and Benchmark, there's an implied 23.06% upside for Select Medical Holdings Corp from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
04/12/2024 | SEM | Buy Now | Select Medical Hldgs | $28.17 | 38.45% | Benchmark | Bill Sutherland | → $39 | Reiterates | Buy → Buy | Get Alert |
11/30/2023 | SEM | Buy Now | Select Medical Hldgs | $28.17 | -7.7% | UBS | A.J. Rice | → $26 | Initiates | → Neutral | Get Alert |
11/08/2023 | SEM | Buy Now | Select Medical Hldgs | $28.17 | 38.45% | Benchmark | Bill Sutherland | → $39 | Reiterates | Buy → Buy | Get Alert |
08/07/2023 | SEM | Buy Now | Select Medical Hldgs | $28.17 | 13.6% | Credit Suisse | Jonathan Yong | $29 → $32 | Maintains | Neutral | Get Alert |
07/20/2023 | SEM | Buy Now | Select Medical Hldgs | $28.17 | 34.9% | RBC Capital | Ben Hendrix | → $38 | Reiterates | Outperform → Outperform | Get Alert |
05/08/2023 | SEM | Buy Now | Select Medical Hldgs | $28.17 | 34.9% | RBC Capital | Ben Hendrix | $32 → $38 | Maintains | Outperform | Get Alert |
05/08/2023 | SEM | Buy Now | Select Medical Hldgs | $28.17 | 2.95% | Credit Suisse | Jonathan Yong | → $29 | Reiterates | → Neutral | Get Alert |
02/27/2023 | SEM | Buy Now | Select Medical Hldgs | $28.17 | 38.45% | Benchmark | Bill Sutherland | → $39 | Reiterates | → Buy | Get Alert |
02/27/2023 | SEM | Buy Now | Select Medical Hldgs | $28.17 | 2.95% | Credit Suisse | Jonathan Yong | $24 → $29 | Maintains | Neutral | Get Alert |
11/07/2022 | SEM | Buy Now | Select Medical Hldgs | $28.17 | 13.6% | RBC Capital | Ben Hendrix | $36 → $32 | Maintains | Outperform | Get Alert |
05/17/2022 | SEM | Buy Now | Select Medical Hldgs | $28.17 | -4.15% | Credit Suisse | Nick Giovacchini | $28 → $27 | Maintains | Neutral | Get Alert |
05/10/2022 | SEM | Buy Now | Select Medical Hldgs | $28.17 | 27.8% | RBC Capital | Ben Hendrix | $42 → $36 | Maintains | Outperform | Get Alert |
03/16/2022 | SEM | Buy Now | Select Medical Hldgs | $28.17 | -0.6% | Credit Suisse | Nick Giovacchini | $37 → $28 | Maintains | Neutral | Get Alert |
03/07/2022 | SEM | Buy Now | Select Medical Hldgs | $28.17 | 49.09% | RBC Capital | Frank Morgan | $47 → $42 | Maintains | Outperform | Get Alert |
01/18/2022 | SEM | Buy Now | Select Medical Hldgs | $28.17 | 24.25% | B of A Securities | Kevin Fischbeck | $40 → $35 | Maintains | Buy | Get Alert |
01/18/2022 | SEM | Buy Now | Select Medical Hldgs | $28.17 | 66.84% | RBC Capital | Ben Hendrix | $50 → $47 | Maintains | Outperform | Get Alert |
08/10/2021 | SEM | Buy Now | Select Medical Holdings | $28.17 | 38.45% | Credit Suisse | — | — | Maintains | Neutral | Get Alert |
05/10/2021 | SEM | Buy Now | Select Medical Holdings | $28.17 | 63.29% | Deutsche Bank | — | — | Maintains | Buy | Get Alert |
The latest price target for Select Medical Hldgs (NYSE: SEM) was reported by Benchmark on April 12, 2024. The analyst firm set a price target for $39.00 expecting SEM to rise to within 12 months (a possible 38.45% upside). 7 analyst firms have reported ratings in the last year.
The latest analyst rating for Select Medical Hldgs (NYSE: SEM) was provided by Benchmark, and Select Medical Hldgs reiterated their buy rating.
There is no last upgrade for Select Medical Hldgs.
There is no last downgrade for Select Medical Hldgs.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Select Medical Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Select Medical Hldgs was filed on April 12, 2024 so you should expect the next rating to be made available sometime around April 12, 2025.
While ratings are subjective and will change, the latest Select Medical Hldgs (SEM) rating was a reiterated with a price target of $0.00 to $39.00. The current price Select Medical Hldgs (SEM) is trading at is $28.17, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.